PTC Therapeutics
PTCT
#3036
Rank
NZ$9.48 B
Marketcap
NZ$113.67
Share price
0.08%
Change (1 day)
1.70%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : NZ$6.09 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are NZ$6.09 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$5.35 B7.84%
2024-12-31NZ$4.97 B15.8%
2023-12-31NZ$4.29 B32.75%
2022-12-31NZ$3.23 B14.03%
2021-12-31NZ$2.83 B18.51%
2020-12-31NZ$2.39 B56.52%
2019-12-31NZ$1.52 B33.42%
2018-12-31NZ$1.14 B245.92%
2017-12-31NZ$0.33 B53.19%
2016-12-31NZ$0.21 B6.24%
2015-12-31NZ$0.20 B358.81%
2014-12-31NZ$44.35 M137.28%
2013-12-31NZ$18.69 M-52.34%
2012-12-31NZ$39.22 M-89.17%
2011-12-31NZ$0.36 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
NZ$142.91 B 2,244.58%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$12.80 B 110.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$0.39 B-93.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.96 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.19 B-96.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
NZ$0.48 B-92.11%๐Ÿ‡บ๐Ÿ‡ธ USA